Your browser doesn't support javascript.
loading
Hospitalizations Among Adults With CKD in Public Renal Specialty Practices: A Retrospective Study From Queensland, Australia.
Diwan, Vishal; Hoy, Wendy E; Wang, Zaimin; Zhang, Jianzhen; Cameron, Anne; Venuthurupalli, Sree K; Fassett, Robert G; Chan, Samuel; Healy, Helen G; Tan, Ken-Soon; Baer, Richard; Mallett, Andrew J; Gray, Nicholas; Mantha, Murty; Cherian, Roy; Mutatiri, Clyson; Madhan, Krishan; Kan, George; Mitchell, Geoffrey; Hossain, Shahadat; Wu, Danielle; Han, Thin; Kark, Adrian; Titus, Thomas; Ranganathan, Dwarakanatan; Bonner, Ann; Govindarajulu, Sridevi.
Affiliation
  • Diwan V; NHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
  • Hoy WE; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Wang Z; NHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
  • Zhang J; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Cameron A; NHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
  • Venuthurupalli SK; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Fassett RG; NHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
  • Chan S; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Healy HG; NHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
  • Tan KS; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Baer R; NHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
  • Mallett AJ; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Gray N; Brisbane, Renal Service, Ipswich Hospital, West Moreton Hospital and Health Service, Ipswich, Queensland, Australia.
  • Mantha M; Tasmanian Health Service Northwest, Hobart, Tasmania, Australia.
  • Cherian R; School of Human Movement and Nutrition Studies, the University of Queensland, Brisbane, Queensland, Australia.
  • Mutatiri C; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Madhan K; NHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
  • Kan G; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Mitchell G; Kidney Health Service, Metro North Hospital and Health Service, Brisbane, Queensland, Australia.
  • Hossain S; Department of Nephrology, Logan Hospital, Logan, Queensland, Australia.
  • Wu D; Department of Nephrology, Logan Hospital, Logan, Queensland, Australia.
  • Han T; Nephrology, Cairns Private Hospital, Cairns, Queensland, Australia.
  • Kark A; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Titus T; College of Medicine & Dentistry, James Cook University, Townsville, Queensland, Australia.
  • Ranganathan D; Renal Unit, The Townsville Hospital, Townsville, Queensland, Australia.
  • Bonner A; Renal Medicine, Sunshine Coast University Hospital, Sunshine Coast, Queensland, Australia.
  • Govindarajulu S; Nephrology, Cairns Private Hospital, Cairns, Queensland, Australia.
Kidney Med ; 5(9): 100700, 2023 Sep.
Article de En | MEDLINE | ID: mdl-37649728
ABSTRACT
Rationale &

Objective:

Little is known about hospital admissions in nondialysis patients with chronic kidney disease (CKD) before death or starting kidney replacement therapy (KRT). Study

Design:

Retrospective observational cohort study. Setting &

Participants:

Hospitalizations among 7,201 patients with CKD from 10 public renal clinics in Queensland (QLD), enrolled in the CKD.QLD registry starting in May 2011, were followed for 25,496.34 person-years until they started receiving KRT or died, or until June 30, 2018. Predictors Demographic and clinical characteristics of patients with CKD.

Outcomes:

Hospital admissions. Analytical

Approach:

We evaluated the association of demographic and clinical features with hospitalizations, length of hospital stay, and cost.

Results:

Approximately 81.5% of the patients were admitted at least once, with 42,283 admissions, costing Australian dollars (AUD) 231 million. The average number of admissions per person-year was 1.7, and the cost was AUD 9,060, 10 times and 2 times their Australian averages, respectively. Single (1-day) admissions constituted 59.2% of all the hospital episodes, led by neoplasms (largely chemotherapy), anemia, CKD-related conditions and eye conditions (largely cataract extractions), but only 14.8% of the total costs. Approximately 41% of admissions were >1-day admissions, constituting 85.2% of the total costs, with cardiovascular conditions, respiratory conditions, CKD-related conditions, and injuries, fractures, or poisoning being the dominant causes. Readmission within 30 days of discharge constituted >42% of the admissions and 46.8% costs. Admissions not directly related to CKD constituted 90% of the admissions and costs. More than 40% of the admissions and costs were through the emergency department. Approximately 19% of the hospitalized patients and 27% of the admissions did not have kidney disease mentioned as either principal or associate causes.

Limitations:

Variable follow-up times because of different dates of consent.

Conclusions:

The hospital burden of patients with CKD is mainly driven by complex multiday admissions and readmissions involving comorbid conditions, which may not be directly related to their CKD. Strategies to prevent these complex admissions and readmissions should minimize hospital costs and outcomes. Plain-Language

Summary:

We analyzed primary causes, types, and costs of hospitalizations among 7,201 patients with chronic kidney disease (CKD) from renal speciality clinics across Queensland, Australia, over an average follow-up of 3.54 years. The average annual cost per person was $9,060, and was the highest in those with more advanced CKD, higher age, and with diabetes. More than 85% of costs were driven by more complex hospitalizations with longer length of stay. Cardiovascular disease was the single largest contributor for hospitalizations, length of hospital stay, and total costs. Readmission within 30 days of discharge, particularly for the same disorder, and multiday admissions should be the main targets for mitigation of hospital costs in this population.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Kidney Med Année: 2023 Type de document: Article Pays d'affiliation: Australie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Kidney Med Année: 2023 Type de document: Article Pays d'affiliation: Australie